MedPath

Bleomycin

​ BLEO 15K Bleomycin sulfate. Bleomycin sulfate powder for injection contains bleomycin sulfate 15,000 IU per vial

Approved
Approval ID

38955939-8d1e-4db2-9aed-3bab72ca5f8f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2023

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 827748190

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bleomycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70121-1567
Product Classification
G
Generic Name
Bleomycin
Product Specifications
Route of AdministrationINTRA-ARTERIAL, INTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 23, 2023
FDA Product Classification

INGREDIENTS (3)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
BLEOMYCIN SULFATEActive
Quantity: 15000 [iU] in 1 1
Code: 7DP3NTV15T
Classification: ACTIM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bleomycin - FDA Drug Approval Details